Wave Life Sciences to Present at the Guggenheim Genomic Medicines and Rare Disease Days

Rhea-AI Summary

Wave Life Sciences (Nasdaq: WVE) announced that CEO Paul Bolno will participate in an analyst-led fireside chat at the Guggenheim Genomic Medicines and Rare Disease Days in New York City on April 3, 2023, at 2:10 p.m. ET. The event aims to discuss the company's commitment to developing innovative genetic medicines for serious diseases.

A live webcast of the presentation will be accessible on the Investor Relations page of their corporate website, with an archived replay available for a limited period post-event.

CAMBRIDGE, Mass., March 29, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in an analyst-led fireside chat at the Guggenheim Genomic Medicines and Rare Disease Days in New York City on Monday, April 3, 2023 at 2:10 p.m. ET.

A live webcast of this presentation will be available on the Investor Relations page of the Wave Life Sciences corporate website at http://ir.wavelifesciences.com. Replay of this presentation will be archived and available on the site for a limited time following the event.

About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization, and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit www.wavelifesciences.com and follow Wave on Twitter @WaveLifeSci.

Investor Contact:
Kate Rausch
617-949-4827
InvestorRelations@wavelifesci.com

Media Contact:
Alicia Suter
617-949-4817
asuter@wavelifesci.com

FAQ

What event is Paul Bolno participating in on April 3, 2023?

Paul Bolno will take part in an analyst-led fireside chat at the Guggenheim Genomic Medicines and Rare Disease Days in New York City.

How can I watch the Wave Life Sciences presentation live?

The presentation can be viewed live on the Investor Relations page of Wave Life Sciences' corporate website.

What is the focus of Wave Life Sciences?

Wave Life Sciences is focused on developing life-changing genetic medicines for patients with devastating diseases.

When will the replay of the Guggenheim event be available?

The replay of the presentation will be archived and available for a limited time after the event.